Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy. | Cell Biosci | 2023 | 36694264 | PubTator, text mining | PubMed |
| Identification of prognostic and predictive biomarkers in high-dimensional data with PPLasso. | BMC Bioinformatics | 2023 | 36690931 | PubTator, text mining | PubMed |
| Deregulated phenotype of autoreactive Th17 and Treg clone cells in pemphigus vulgaris after in-vitro treatment with desmoglein antigen (Dsg-3). | Immunobiology | 2023 | 36689824 | PubTator, text mining | PubMed |
| Compartmentalization and persistence of dominant (regulatory) T cell clones indicates antigen skewing in juvenile idiopathic arthritis. | Elife | 2023 | 36688525 | PubTator, text mining | PubMed |
| The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer. | Int J Mol Sci | 2023 | 36675020 | PubTator, text mining | PubMed |
| Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous Cancers. | Int J Mol Sci | 2023 | 36674809 | PubTator, text mining | PubMed |
| The Immunosuppressive Effect of TNFR2 Expression in the Colorectal Cancer Microenvironment. | Biomedicines | 2023 | 36672682 | PubTator, text mining | PubMed |
| Configuring Therapeutic Aspects of Immune Checkpoints in Lung Cancer. | Cancers (Basel) | 2023 | 36672492 | PubTator, text mining | PubMed |
| Investigation of the Molecular Evolution of Treg Suppression Mechanisms Indicates a Convergent Origin. | Curr Issues Mol Biol | 2023 | 36661528 | PubTator, text mining | PubMed |
| CMTM6 is highly expressed in lung adenocarcinoma and can be used as a biomarker of a poor diagnosis. | PeerJ | 2023 | 36643629 | PubTator, text mining | PubMed |
| Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma. | J Clin Transl Hepatol | 2023 | 36643033 | PubTator, text mining | PubMed |
| Integrated analysis of single-cell RNA-seq and bulk RNA-seq unveils heterogeneity and establishes a novel signature for prognosis and tumor immune microenvironment in ovarian cancer. | J Ovarian Res | 2023 | 36642706 | PubTator, text mining | PubMed |
| Immunomodulatory IL-23 receptor antagonist peptide nanocoatings for implant soft tissue healing. | Dent Mater | 2023 | 36642687 | PubTator, text mining | PubMed |
| S-adenosylmethionine blocks tumorigenesis and with immune checkpoint inhibitor enhances anti-cancer efficacy against BRAF mutant and wildtype melanomas. | Neoplasia | 2023 | 36638586 | PubTator, text mining | PubMed |
| CTLA4+CD4+CXCR5-FOXP3+ T cells associate with unfavorable outcome in patients with chronic HBV infection. | BMC Immunol | 2023 | 36635631 | PubTator, text mining | PubMed |
| Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. | Proc Natl Acad Sci U S A | 2023 | 36634138 | PubTator, text mining | PubMed |
| Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities. | J Biomed Sci | 2023 | 36627707 | PubTator, text mining | PubMed |
| The Role of B Cell and T Cell Glycosylation in Systemic Lupus Erythematosus. | Int J Mol Sci | 2023 | 36614306 | PubTator, text mining | PubMed |
| Cell Pair Algorithm-Based Immune Infiltrating Cell Signature for Improving Outcomes and Treatment Responses in Patients with Hepatocellular Carcinoma. | Cells | 2023 | 36611994 | PubTator, text mining | PubMed |
| Liquid biopsy for monitoring of tumor dormancy and early detection of disease recurrence in solid tumors. | Cancer Metastasis Rev | 2023 | 36607507 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=36